Shelton Capital Management trimmed its holdings in MAXIMUS, Inc. (NYSE:MMS) by 5.9% in the 3rd quarter, HoldingsChannel reports. The firm owned 3,508 shares of the health services provider’s stock after selling 219 shares during the quarter. Shelton Capital Management’s holdings in MAXIMUS were worth $240,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of MMS. William Blair Investment Management LLC boosted its stake in MAXIMUS by 241.0% in the 2nd quarter. William Blair Investment Management LLC now owns 1,490,894 shares of the health services provider’s stock worth $105,033,000 after purchasing an additional 1,053,647 shares during the period. DekaBank Deutsche Girozentrale boosted its stake in MAXIMUS by 151.2% in the 3rd quarter. DekaBank Deutsche Girozentrale now owns 324,114 shares of the health services provider’s stock worth $22,047,000 after purchasing an additional 195,099 shares during the period. Copeland Capital Management LLC boosted its stake in MAXIMUS by 75.5% in the 2nd quarter. Copeland Capital Management LLC now owns 390,987 shares of the health services provider’s stock worth $27,545,000 after purchasing an additional 168,259 shares during the period. Amundi Pioneer Asset Management Inc. raised its holdings in shares of MAXIMUS by 7,431.9% during the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 148,680 shares of the health services provider’s stock worth $10,553,000 after acquiring an additional 146,706 shares in the last quarter. Finally, Pier Capital LLC purchased a new stake in shares of MAXIMUS during the 2nd quarter worth approximately $6,874,000. Institutional investors and hedge funds own 94.19% of the company’s stock.

In related news, Vice Chairman Richard A. Montoni sold 11,639 shares of MAXIMUS stock in a transaction dated Wednesday, September 30th. The shares were sold at an average price of $68.41, for a total transaction of $796,223.99. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, General Counsel David Francis sold 6,677 shares of MAXIMUS stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $70.00, for a total transaction of $467,390.00. Following the transaction, the general counsel now directly owns 10,024 shares of the company’s stock, valued at $701,680. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 77,122 shares of company stock valued at $5,394,762. 2.00% of the stock is owned by corporate insiders.

Shares of MMS opened at $72.31 on Friday. The stock has a market capitalization of $4.43 billion, a price-to-earnings ratio of 21.85 and a beta of 0.87. MAXIMUS, Inc. has a 1 year low of $46.42 and a 1 year high of $80.50. The business’s 50 day simple moving average is $69.74 and its 200-day simple moving average is $71.42. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.95 and a quick ratio of 1.95.

MAXIMUS (NYSE:MMS) last posted its quarterly earnings data on Wednesday, November 18th. The health services provider reported $1.02 EPS for the quarter, topping the consensus estimate of $0.89 by $0.13. MAXIMUS had a net margin of 6.41% and a return on equity of 17.29%. On average, sell-side analysts expect that MAXIMUS, Inc. will post 3.27 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, November 30th. Investors of record on Friday, November 13th will be paid a dividend of $0.28 per share. The ex-dividend date of this dividend is Thursday, November 12th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.55%. MAXIMUS’s dividend payout ratio is presently 30.11%.

Several analysts have recently issued reports on MMS shares. TheStreet raised MAXIMUS from a “c+” rating to a “b-” rating in a report on Tuesday, November 10th. KeyCorp upped their price objective on MAXIMUS from $80.00 to $84.00 and gave the stock an “overweight” rating in a report on Friday, August 7th. Two research analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the stock. MAXIMUS has an average rating of “Buy” and a consensus price target of $83.50.

MAXIMUS Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. It operates through three segments: U.S. Health and Human Services, U.S. Federal Services, and Outside the U.S. The U.S. Health and Human Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.

Featured Article: Limitations to arbitrage trading

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).

Institutional Ownership by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.